APA (7th ed.) Citation

W, Z., X, W., L, H., C, Z., C, W., D, K., . . . Y, Z. (2024). SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis. Nature communications, 15(1), 7522. https://doi.org/10.1038/s41467-024-51860-2

Chicago Style (17th ed.) Citation

W, Zhao, et al. "SLC13A3 Is a Major Effector Downstream of Activated β-catenin in Liver Cancer Pathogenesis." Nature Communications 15, no. 1 (2024): 7522. https://doi.org/10.1038/s41467-024-51860-2.

MLA (9th ed.) Citation

W, Zhao, et al. "SLC13A3 Is a Major Effector Downstream of Activated β-catenin in Liver Cancer Pathogenesis." Nature Communications, vol. 15, no. 1, 2024, p. 7522, https://doi.org/10.1038/s41467-024-51860-2.